Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kavindhran Velen

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
JMIR Formative Research|November 13, 2025
Shesha, a WhatsApp Chatbot for Linking Household Contacts to Tuberculosis Treatment or Preventive Therapy in South Africa: Design and DevelopmentDon Lawrence Mudzengi, Thobani Ntshiqa, Yohhei Hamada, et al.
PLOS Global Public Health|October 27, 2023
Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South AfricaRachel Mukora, Barack Ahumah, Noriah Maraba, et al.
BMC Public Health|July 3, 2026
Cost-effectiveness analysis of implementing a medication monitor and differentiated care approach among people with TB in South AfricaRachel Mukora, Resignation Pelusa, Noriah Maraba, et al.
Plos One|March 3, 2018
Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South AfricaLiesl Page-Shipp, James J Lewis, Kavindhran Velen, et al.
Plos One|March 18, 2022
Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold minersViolet N Chihota, Thobani Ntshiqa, Pholo Maenetje, et al.
BMJ Public Health|February 28, 2025
Health-seeking behaviour and patient-related factors associated with the time to TB treatment initiation in four African countries: a cross-sectional surveyFarzana Sathar, Salome Charalambous, Kavindhran Velen, et al.
Trials|June 10, 2021
Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trialNoriah Maraba, Catherine Orrell, Candice M Chetty-Makkan, et al.
Emerging Microbes & Infections|February 8, 2023
Designing molecular diagnostics for current tuberculosis drug regimensSophia B Georghiou, Margaretha de Vos, Kavindhran Velen, et al.
BMC Infectious Diseases|January 21, 2022
Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort studyIan Wrohan, Thu Anh Nguyen, Viet Nhung Nguyen, et al.
Gates Open Research|August 10, 2023
Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South AfricaThobani Ntshiqa, Violet Chihota, Raoul Mansukhani, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
JMIR Formative Research|November 13, 2025
Shesha, a WhatsApp Chatbot for Linking Household Contacts to Tuberculosis Treatment or Preventive Therapy in South Africa: Design and DevelopmentDon Lawrence Mudzengi, Thobani Ntshiqa, Yohhei Hamada, et al.
PLOS Global Public Health|October 27, 2023
Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South AfricaRachel Mukora, Barack Ahumah, Noriah Maraba, et al.
BMC Public Health|July 3, 2026
Cost-effectiveness analysis of implementing a medication monitor and differentiated care approach among people with TB in South AfricaRachel Mukora, Resignation Pelusa, Noriah Maraba, et al.
Plos One|March 3, 2018
Household point of care CD4 testing and isoniazid preventive therapy initiation in a household TB contact tracing programme in two districts of South AfricaLiesl Page-Shipp, James J Lewis, Kavindhran Velen, et al.
Plos One|March 18, 2022
Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold minersViolet N Chihota, Thobani Ntshiqa, Pholo Maenetje, et al.
BMJ Public Health|February 28, 2025
Health-seeking behaviour and patient-related factors associated with the time to TB treatment initiation in four African countries: a cross-sectional surveyFarzana Sathar, Salome Charalambous, Kavindhran Velen, et al.
Trials|June 10, 2021
Evaluation of adherence monitoring system using evriMED with a differentiated response compared to standard of care among drug-sensitive TB patients in three provinces in South Africa: a protocol for a cluster randomised control trialNoriah Maraba, Catherine Orrell, Candice M Chetty-Makkan, et al.
Emerging Microbes & Infections|February 8, 2023
Designing molecular diagnostics for current tuberculosis drug regimensSophia B Georghiou, Margaretha de Vos, Kavindhran Velen, et al.
BMC Infectious Diseases|January 21, 2022
Predictors of treatment outcomes among patients with multidrug-resistant tuberculosis in Vietnam: a retrospective cohort studyIan Wrohan, Thu Anh Nguyen, Viet Nhung Nguyen, et al.
Gates Open Research|August 10, 2023
Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South AfricaThobani Ntshiqa, Violet Chihota, Raoul Mansukhani, et al.
Pageof 5